Woodline Partners’s Forte Biosciences FBRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.29M | Buy |
331,987
+127,165
| +62% | +$1.64M | 0.02% | 591 |
|
|
2025
Q1 | $1.59M | Buy |
204,822
+547
| +0.3% | +$4.25K | 0.01% | 703 |
|
|
2024
Q4 | $4.64M | Buy |
+204,275
| New | +$4.64M | 0.03% | 497 |
|
|
2021
Q4 | – | Sell |
-5,724
| Closed | -$424K | – | 729 |
|
|
2021
Q3 | $424K | Sell |
5,724
-2,023
| -26% | -$150K | 0.01% | 554 |
|
|
2021
Q2 | $6.51M | Buy |
7,747
+134
| +2% | +$113K | 0.12% | 193 |
|
|
2021
Q1 | $6.52M | Sell |
7,613
-78
| -1% | -$66.8K | 0.14% | 169 |
|
|
2020
Q4 | $7M | Buy |
+7,691
| New | +$7M | 0.19% | 139 |
|